Molecular biology for formyl peptide receptors in human diseases

J Mol Med (Berl). 2013 Jul;91(7):781-9. doi: 10.1007/s00109-013-1005-5. Epub 2013 Feb 13.

Abstract

Leukocytes accumulate at sites of inflammation and immunological reaction in response to locally existing chemotactic mediators. The first chemotactic factors structurally defined were N-formyl peptides. Subsequently, numerous ligands were identified to activate formyl peptide receptors (FPRs) that belong to the seven-transmembrane G protein-coupled receptor superfamily. FPRs interact with this menagerie of structurally diverse pro- and anti-inflammatory ligands to possess important regulatory effects in multiple diseases, including inflammation, amyloidosis, Alzheimer's disease, prion disease, acquired immunodeficiency syndrome, obesity, diabetes, and cancer. How these receptors recognize diverse ligands and how they contribute to disease pathogenesis and host defense are basic questions currently under investigation that would open up new avenues for the future management of inflammation-related diseases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acquired Immunodeficiency Syndrome / metabolism
  • Animals
  • Diabetes Mellitus / metabolism
  • Humans
  • Inflammation / metabolism
  • Neoplasms / metabolism
  • Neurodegenerative Diseases / metabolism
  • Obesity / metabolism
  • Receptors, Formyl Peptide / physiology*

Substances

  • Receptors, Formyl Peptide